These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15027316)

  • 1. [Atherosclerosis and metabolic disease].
    Tsuji M; Ishii J
    Rinsho Byori; 2004 Feb; 52(2):126-35. PubMed ID: 15027316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging role of lipoproteins in atherogenesis: beyond LDL cholesterol.
    Nicholls S; Lundman P
    Semin Vasc Med; 2004 May; 4(2):187-95. PubMed ID: 15478040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Postgrad Med J; 2008 Nov; 84(997):590-8. PubMed ID: 19103817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic approaches to dyslipidemia in diabetes mellitus and metabolic syndrome.
    Cottrell DA; Marshall BJ; Falko JM
    Curr Opin Cardiol; 2003 Jul; 18(4):301-8. PubMed ID: 12858129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
    Temelkova-Kurktschiev T; Hanefeld M
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R; Borggreve SE; Dullaart RP
    Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus.
    Brunzell JD; Ayyobi AF
    Am J Med; 2003 Dec; 115 Suppl 8A():24S-28S. PubMed ID: 14678862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDL cholesterol and protective factors in atherosclerosis.
    Assmann G; Gotto AM
    Circulation; 2004 Jun; 109(23 Suppl 1):III8-14. PubMed ID: 15198960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyslipidemia of the metabolic syndrome.
    Ruotolo G; Howard BV
    Curr Cardiol Rep; 2002 Nov; 4(6):494-500. PubMed ID: 12379172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDL as a target in the treatment of atherosclerotic cardiovascular disease.
    Linsel-Nitschke P; Tall AR
    Nat Rev Drug Discov; 2005 Mar; 4(3):193-205. PubMed ID: 15738977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The physiology of lipoproteins.
    Tulenko TN; Sumner AE
    J Nucl Cardiol; 2002; 9(6):638-49. PubMed ID: 12466789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerotic risk factors in cardiovascular disease.
    LaRosa JC
    J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical diagnosis of lipid disorders.
    Jones PH
    Clin Cornerstone; 1998; 1(1):15-30. PubMed ID: 10682161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance, small LDL particles, and risk for atherosclerotic disease.
    Toth PP
    Curr Vasc Pharmacol; 2014; 12(4):653-7. PubMed ID: 23627975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial lipemia and cardiovascular disease.
    Hyson D; Rutledge JC; Berglund L
    Curr Atheroscler Rep; 2003 Nov; 5(6):437-44. PubMed ID: 14525676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.